And the results of that trial were published last August (2017): Title: Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial Authors: Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T Journal: Lancet 2017 Aug 3
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Watkins A.R., Fialka N., El-Andari R., Kang J.J., Bozso S.J., Nagendran J
Combination superior: 15-20% vs 5-10% weight loss
The key is not abstinence but rather understanding how to minimize interference
According to the World Health Organisation, obesity has nearly tripled since 1975, underscoring the urgent need for effective weight management strategies
If you're looking for an alternative that combines physician supervision with transparent pricing, consider FormBlends' physician-supervised GLP-1 program